Valuation: AstraZeneca PLC

Market Cap 264B 398,605B 226B 212B 194B 365B 25,153B 369B 2,499B 973B 12,690B 991B 969B 42,026B P/E 2026 *
21.9x
P/E 2027 * 19x
Enterprise Value 283B 427,802B 243B 227B 208B 392B 26,995B 396B 2,682B 1,044B 13,620B 1,063B 1,040B 45,104B EV / Sales 2026 *
4.48x
EV / Sales 2027 * 4.12x
Free-Float
96.63%
Yield 2026 *
1.96%
Yield 2027 * 2.09%
1 day+1.50%
1 week+7.24%
Current month+1.23%
1 month+0.41%
3 months-2.90%
6 months-10.32%
Current year-3.90%
1 week 64,000
Extreme 64000
68,000
1 month 60,650
Extreme 60650
69,800
Current year 60,650
Extreme 60650
80,275
1 year 50,650
Extreme 50650
80,275
3 years 24,182
Extreme 24182
80,275
5 years 4,889
Extreme 4889
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+7.24% - - 264B
-1.06%+0.65%+77.42%+122.82% 1,100B
+0.04%+0.75%+53.10%+64.29% 658B
+0.48%+2.65%+28.06%+81.19% 470B
+0.11%+2.07%+44.68%+44.70% 372B
-0.08%+1.05%+26.84%+42.01% 304B
-0.75%+2.87%+4.41%+14.74% 264B
-0.36%+3.99%+53.31%+72.49% 239B
+0.89%+4.04%-11.23%-51.81% 213B
+1.38%+3.72%+30.33%+93.56% 184B
Average +0.22%+3.01%+34.10%+53.78% 422.54B
Weighted average by Cap. -0.08%+2.21%+46.05%+71.62%

Financials

2026 *2027 *
Net sales 63.25B 95,558B 54.2B 50.79B 46.39B 87.55B 6,030B 88.41B 599B 233B 3,042B 237B 232B 10,075B 66.84B 100,980B 57.27B 53.67B 49.02B 92.52B 6,372B 93.43B 633B 246B 3,215B 251B 245B 10,647B
Net income 12.02B 18,163B 10.3B 9.65B 8.82B 16.64B 1,146B 16.8B 114B 44.33B 578B 45.14B 44.16B 1,915B 13.69B 20,680B 11.73B 10.99B 10.04B 18.95B 1,305B 19.13B 130B 50.47B 658B 51.4B 50.28B 2,180B
Net Debt 19.33B 29,198B 16.56B 15.52B 14.17B 26.75B 1,842B 27.01B 183B 71.26B 930B 72.57B 70.98B 3,078B 11.65B 17,604B 9.98B 9.36B 8.55B 16.13B 1,111B 16.29B 110B 42.96B 560B 43.75B 42.8B 1,856B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-08-25 ARS 67,800.00 +1.50% 942
26-08-24 ARS 66,800.00 +0.87% 636
26-08-21 ARS 66,225.00 +1.34% 1,178
26-08-20 ARS 65,350.00 +0.35% 4,619
26-08-19 ARS 65,125.00 +3.01% 4,014
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
170.10USD
Average target price
212.30USD
Spread / Average Target
+24.80%

Quarterly revenue - Rate of surprise